EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

Flash talks on Allergen Immunotherapy 1

Sunday 02 Jun, 08:30 AM - 10:00 AM Valencia, Spain
Cordoba Flash Talks
08:30
Mesoporous silica nanoparticles for allergy diagnosis and therapy
08:37
A dose ranging study of sting challenge and specific lgE, IgG4, venom skin test and basophil activation responses to ant venom immunotherapy with and without delta-inulin adjuvant
08:44
The cross-protective activity of allergen immunotherapy-induced blocking antibodies accords with the structural identity of allergens
08:51
Polyclonal desensitization impairs mast cell responses in an allergen specific manner without compromising IgE signaling ability
08:58
The definition of the standardization unit of cat allergen extracts and its impact on their potency
09:05
Development and validation of an in-house monoclonal antibody-based ELISA method for the quantification of Jun a 1 in Juniperus ashei pollen extracts
09:12
Fast dissociation of the IgE/FcεRI complex by engaging the Cε2 domain with allosteric, bi-specific IgE inhibitors
09:19
Development of a thermosensitive poloxamer formulation designed to provide a controlled release of the active pharmaceutical ingredient in birch pollen allergen immunotherapy
09:26
A New Immunotoxin Design against Allergy Based on the IL33 Cytokine and the Ribotoxin α-Sarcin
09:33
ILIT.NU: Titration of Allergen for Treatment of Grass Pollen Induced Rhinoconjunctivitis with Intralymphatic Immunotherapy
09:40
Allergen immunotherapy in patients with allergic rhinitis and asthma associated with reduced risk of severe COVID-19
09:47
A comparative dose-response study of prophylactic peanut allergy SLIT and EPIT in Brown Norway rats